Your browser doesn't support javascript.
loading
Prognostic Nutrition Index as an Indicator of Therapeutic Response to Lenvatinib Therapy in Hepatocellular Carcinoma.
Shibano, Masahito; Takahashi, Katsuyuki; Takahashi, Masaya; Uchida-Kobayashi, Sawako; Kawada, Norifumi; Nakamura, Yasutaka; Otori, Toru; Nagayama, Katsuya.
Afiliação
  • Shibano M; Department of Pharmacy, Osaka Metropolitan University Hospital, Osaka, Japan.
  • Takahashi K; Division of Social Pharmacy, Faculty of Pharmacy, Kindai University, Osaka, Japan; k.taka@phar.kindai.ac.jp.
  • Takahashi M; Department of Pharmacy, Osaka Metropolitan University Hospital, Osaka, Japan.
  • Uchida-Kobayashi S; Department of Premier Preventive Medicine, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
  • Kawada N; Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
  • Nakamura Y; Department of Pharmacy, Osaka Metropolitan University Hospital, Osaka, Japan.
  • Otori T; Division of Social Pharmacy, Faculty of Pharmacy, Kindai University, Osaka, Japan.
  • Nagayama K; Department of Pharmacy, Osaka Metropolitan University Hospital, Osaka, Japan.
Anticancer Res ; 42(12): 6019-6026, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36456132
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2022 Tipo de documento: Article